Generation Bio Co., headquartered in the United States, is a pioneering biotechnology company focused on developing transformative gene therapies. Founded in 2016, the company has rapidly advanced its proprietary gene delivery platform, which aims to provide durable and potentially curative treatments for genetic diseases. With a strong emphasis on innovation, Generation Bio's core offerings include its unique non-viral gene therapy solutions, designed to overcome the limitations of traditional viral vectors. This approach positions the company at the forefront of the gene therapy industry, enabling it to address a wide range of genetic disorders. Notable achievements include significant funding rounds and strategic partnerships that have bolstered its market presence. As a leader in the biotechnology sector, Generation Bio is committed to advancing the future of medicine through its cutting-edge research and development initiatives.
How does Generation Bio Co.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Generation Bio Co.'s score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Generation Bio Co., headquartered in the US, currently does not have available carbon emissions data for the most recent year. As such, there are no specific figures regarding their Scope 1, Scope 2, or Scope 3 emissions. Additionally, the company has not outlined any reduction targets or commitments related to climate initiatives, nor are there any climate pledges documented. In the absence of emissions data and reduction initiatives, it is important to note that Generation Bio Co. may still be developing its climate strategy in line with industry standards. The company’s future commitments and actions will be crucial in addressing climate change and reducing its carbon footprint.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Generation Bio Co. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.


You're welcome to quote or reference data from this page, but please include a visible link back to this URL.
Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.